Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)
Clinical trial NCT01801449 · COMPLETED
Trial details
- NCT number
- NCT01801449
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-12
- Primary completion
- 2016-04-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.